Literature DB >> 21326972

Prevalence of left ventricular diastolic dysfunction in newly diagnosed Nigerians with systemic hypertension: a pulsed wave Doppler echocardiographic study.

G U Adamu1, A I Katibi, George O Opadijo, A B O Omotoso, A M Araoye.   

Abstract

BACKGROUND: Systemic hypertension is a common cause of left ventricular diastolic dysfunction. However, its prevalence in Nigerians with untreated systemic hypertension is unknown.
OBJECTIVE: To determine the prevalence of left ventricular diastolic dysfunction in newly diagnosed Nigerians with systemic hypertension using Doppler transmitral inflow and pulmonary venous flow velocities.
METHODS: Two-dimensional echocardiography including Doppler was performed on 150 newly diagnosed cases of systemic hypertension and 150 normotensive controls. They were divided into hypertensives without left ventricular hypertrophy and those with left ventricular hypertrophy based on echocardiographically determined left ventricular mass index. Pulsed Doppler transmitral inflow and the pulmonary venous flow waves were used to categorise the patterns of diastolic dysfunction.
RESULTS: The hypertensives and the normotensive controls were comparable in their baseline characteristics. The E/A ratio differed significantly between hypertensives with and without left ventricular hypertrophy and controls (1.00+0.30, 1.04±0.42, 1.33±0.27, p < 0.001). Left ventricular diastolic dysfunction occurred in 62% of systemic hypertension and 11.3% of the controls. Impaired relaxation was the commonest pattern (84.9%) of diastolic dysfunction.
CONCLUSION: Our study showed that left ventricular diastolic dysfunction is prevalent in Nigerians with newly diagnosed systemic hypertension and effort should be made to routinely screen for them.

Entities:  

Keywords:  Diastolic dysfunction; Echocardiography; Nigerians; Systemic hypertension

Mesh:

Year:  2010        PMID: 21326972      PMCID: PMC2956289     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  24 in total

1.  Gender difference in diastolic function in hypertension (the HyperGEN study).

Authors:  Jonathan N Bella; Vittorio Palmieri; Dalane W Kitzman; Jennifer E Liu; Albert Oberman; Steven C Hunt; Paul N Hopkins; D C Rao; Donna K Arnett; Richard B Devereux
Journal:  Am J Cardiol       Date:  2002-05-01       Impact factor: 2.778

2.  2005 Young Investigator's Award Winner: Assessment of diastolic function in newly diagnosed hypertensives.

Authors:  M Masliza; S Mohd Daud; Y Khalid
Journal:  Ann Acad Med Singap       Date:  2005-12       Impact factor: 2.473

3.  Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample.

Authors:  M Fischer; A Baessler; H W Hense; C Hengstenberg; M Muscholl; S Holmer; A Döring; U Broeckel; G Riegger; H Schunkert
Journal:  Eur Heart J       Date:  2003-02       Impact factor: 29.983

4.  Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.

Authors:  K Wachtell; G Smith; E Gerdts; B Dahlöf; M S Nieminen; V Papademetriou; J N Bella; H Ibsen; J Rokkedal; R B Devereux
Journal:  Am J Cardiol       Date:  2000-02-15       Impact factor: 2.778

5.  Left ventricular diastolic function in essential hypertensive patients: influence of age and left ventricular geometry.

Authors:  Eduardo Cantoni Rosa; Valdir Ambrósio Moysés; Ivan Rivera; Ricardo da Cintra Sesso; Nárcia Kohlmann; Maria Tereza Zanella; Artur Beltrame Ribeiro; Osvaldo Kohlmann
Journal:  Arq Bras Cardiol       Date:  2002-05       Impact factor: 2.000

6.  Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.

Authors:  Kristian Wachtell; Jonathan N Bella; Jens Rokkedal; Vittorio Palmieri; Vasilios Papademetriou; Björn Dahlöf; Tapio Aalto; Eva Gerdts; Richard B Devereux
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

7.  Diastolic dysfunction in persons with hypertensive heart failure.

Authors:  Imhogene Albert Oyati; Sulei Solomon Danbauchi; Mohammed Ahmed Alhassan; Mohammed S Isa
Journal:  J Natl Med Assoc       Date:  2004-07       Impact factor: 1.798

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  The relationship between diastolic dysfunction and level of blood pressure in Blacks.

Authors:  S O Ike; B J C Onwubere
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

Review 10.  Diastolic dysfunction in hypertension.

Authors:  Michel Slama; Dinko Susic; Jasmina Varagic; Edward D Frohlich
Journal:  Curr Opin Cardiol       Date:  2002-07       Impact factor: 2.161

View more
  3 in total

1.  Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review.

Authors:  Okechukwu S Ogah; Ikechi Okpechi; Innocent I Chukwuonye; Joshua O Akinyemi; Basden Jc Onwubere; Ayodele O Falase; Simon Stewart; Karen Sliwa
Journal:  World J Cardiol       Date:  2012-12-26

2.  Alterations in diastolic function in masked hypertension: findings from the masked hypertension study.

Authors:  Yukiko Oe; Daichi Shimbo; Joji Ishikawa; Kazue Okajima; Takuya Hasegawa; Keith M Diaz; Paul Muntner; Shunichi Homma; Joseph E Schwartz
Journal:  Am J Hypertens       Date:  2013-02-27       Impact factor: 2.689

3.  Relationship of left ventricular and atrial dimensions with moderate to severe left ventricular diastolic dysfunction (grade II and above).

Authors:  Muhammad Hamza; Mishal Fatima; Muhammad Masood; Hafiz Umar Masood; Ghazal Tasleem; Hassaan Ahmed; Maha Nadir; Zubair Satti
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.